Not Finding What You're Looking For?
Depression & Spinal Cord Injury
Depression is more common in the SCI population— about one in five people. Estimated rates of depression among people with SCI range from 11% to 37%.
In the News
Post-Doctoral Fellow
We are seeking for a new Post-Doctoral fellow to work in our new Biology Lab at the Shirley Ryan AbilityLab.
In the News
In the News: Laura Ferrio, Actor Bob Odenkirk and Research Participant Maria Odenkirk Featured in SkyRise Story on Chicago Public Radio
On Nov. 2, Reset, the midday show on WBEZ-FM — Chicago’s NPR affiliate — ran a segment on SkyRise Chicago, Shirley Ryan AbilityLab’s annual fundraising climb up Willis Tower, that included perspectives from Laura Ferrio, chief operating officer.
News
Mentoring Resources: C-STAR and NIH
C-STAR shares highlights that have most impacted our experience with mentorship and related topics of value.
Page
Meet Charles and Discover Music Therapy
Watch this video to meet Charles C. and see his experience at Shirley Ryan AbilityLab after experiencing issues related to his cervical stenosis.
Patient Story
Efficacy Verification in Early Diagnosis and Management of Lymphedema through Home Body Water Analyzer
This clinicial trial through Shirley Ryan AbilityLab is compares water body scales used in the clinic and at home to detect early onset breast cancer-related lymphedema.
Age Range
18+
Clinical Trial
Improving Adherence to Spinal Cord Injury Exercise Guidelines Using Smartphone-Based Technology and E-coaching: A Proof-of-Concept SMART-Design Study
Trial of an SCI-specific smartphone exercise app for a 2-week period and providing feedback.
Age Range
18 - 80
Clinical Trial
Brain-Based and Clinical Phenotyping of Pain Pharmacotherapy in Knee Osteoarthritis (PREDICT)
This is a clinical trial of people who have pain due to knee osteoarthritis at Northwestern University Feinberg School of Medicine in collaboration with Shirley Ryan AbilityLab. The study will last for about 20 weeks. 180 qualified participants will be randomly assigned in a 1:1:1 ratio (60 participants per group) to one of three treatment groups: duloxetine, celecoxib or placebo. Participants will have an X-ray, knee MRI, brain MRI, blood draws, pain sensitivity testing and will be asked to fill out questionnaires. The purpose of this study is to predict which participants will respond to the treatment.
Age Range
40-99
Clinical Trial
Direct Support Professionals: Complete Short, Online "Microlessons" on Motivational Interviewing and Person-Centered Services
Age Range
18+
Clinical Trial
Learning and Evaluating Assistive Device Control with Autonomous Corrections
The Shirley Ryan Ability Lab is conducting a research study that will investigate a new approach for providing assistance for controlling an assistive device with limited interfaces for motor-impaired individuals.
Age Range
18 - 99
Clinical Trial
Improving Adherence to Spinal Cord Injury Exercise Guidelines Using Smartphone-Based Technology and E-coaching: A Proof-of-Concept SMART-Design Study
Age Range
18-79
Clinical Trial
Characterization and Clinical Trial of a Variable Friction Shoe, a new Paradigm of Reduced-Constraint Locomotor Therapy for People Exhibiting Foot Drop due to Stroke
To evaluate the effect of a variable friction shoe on walking in individuals with chronic stroke and foot drop.
Age Range
18+
Clinical Trial
